Latest in News & Research

Systemic Antibiotics in First Year of Life Tied to Higher Atopic Dermatitis Risk

Dose-response relationship seen for number of antibiotic courses and atopic dermatitis risk

By Lori Solomon (HealthDay News) | | May 08, 2024

Trifarotene Plus Skin Care Beneficial for Acne Vulgaris

Improvement seen in acne-induced hyperpigmentation overall disease severity score at week 12, but not week 24

By Elana Gotkine (HealthDay News) | | May 08, 2024

Study Addresses Clinical Features, Surgical Management of Lip Squamous Cell Carcinoma

Reconstruction algorithm with a 50 percent cutoff value is suggested based on cohort of 34 patients

By Dermsquared Editorial Team | | May 08, 2024

Can Adalimumab Improve Hematologic Abnormalities in Hidradenitis Suppurativa?

Greater improvements seen in hematologic abnormalities for patients with clinical response to adalimumab

By Dermsquared Editorial Team | | May 08, 2024

Melanoma Monday: Transforming Lives Through Early Detection and Prevention

The first Monday in May is Melanoma Monday—explore its role in advancing public health and how dermatologists can spread its message to their patients

By Dermsquared Editorial Team | | May 06, 2024

LAUNCH ALERT: SPEVIGO expanded indications now available in the US

The US FDA’s expanded approval makes SPEVIGO the first targeted therapy that addresses the need for acute and chronic treatment for patients with GPP.

By Dermsquared Editorial Team | | May 02, 2024

International Consensus Achieved for Generalized Pustular Psoriasis

Final definition is 'systemic inflammatory disease characterized by cutaneous erythema and macroscopically visible sterile pustules'

By Dermsquared Editorial Team | | May 01, 2024

Increase Seen in Melanoma Incidence With No Increase in Mortality

Subsequent increase seen for men, no change for women; no temporal trends in mortality noted during 1999 to 2019

By Dermsquared Editorial Team | | May 01, 2024

Stigma Affects Quality of Life in Children With Chronic Skin Conditions

Stigma correlates with depression and differs based on level of severity and visibility

By Lori Solomon (HealthDay News) | | April 30, 2024

Tobacco Smoking Reduces the Odds of Psoriasis Improvement

Achievement of ≥75 percent reduction in Psoriasis Area and Severity Index lower in both current, former smokers

By Lori Solomon (HealthDay News) | | April 24, 2024

Dupilumab Safe, Effective Over Long Term for Atopic Dermatitis

Improvements seen in patient-reported outcome measures, including Patient-Oriented Eczema Measure, Dermatology Life Quality Index

By Dermsquared Editorial Team | | April 24, 2024

Facial Skin Cancer Surgery Does Not Influence Quality of Life

Low scores seen for perceived stigmatization and body image concerns; satisfaction with facial appearance, psychological distress improved

By Dermsquared Editorial Team | | April 24, 2024

Atopic Dermatitis Negatively Impacts Mental Health

Greater negative impact seen among patients with severe atopic dermatitis

By Lori Solomon (HealthDay News) | | April 23, 2024

Review Explores Cutaneous Manifestations of Myelodysplastic Syndrome

Common manifestations include neutrophilic dermatoses, vasculitis, granulomatous, connective tissue disease

By Elana Gotkine (HealthDay News) | | April 19, 2024

Erenumab Effective, Safe for Rosacea-Linked Erythema, Flushing

Reduction seen in mean number of days with moderate-to-extreme flushing, moderate-to-severe erythema

By Elana Gotkine (HealthDay News) | | April 17, 2024

Once-Weekly Pulsed Dye Laser Beneficial for Port-Wine Birthmarks

Seven of 10 infants had near-total or total clearance after two months with once-weekly treatments

By Dermsquared Editorial Team | | April 17, 2024

Best Results for Classifying Malignant Melanoma Seen When Clinicians Work With AI

Less heterogeneity in sensitivity, specificity, accuracy seen when clinicians worked in unison with artificial intelligence

By Dermsquared Editorial Team | | April 17, 2024

CDC Warns of 19 Cases of Botched Botox Shots in 9 States

By Robin | | April 16, 2024

FDA Approves New Antibiotic for Three Indications

Zevtera approved for S. aureus bloodstream infections, acute bacterial skin/skin structure infections, and bacterial pneumonia

By Lori Solomon (HealthDay News) | | April 11, 2024

Bioactive Retinol Efficacious for Improving Signs of Photoaging

Improvement seen in all signs of photoaging as early as week 4 and through 12 weeks, with no major irritation

By Elana Gotkine (HealthDay News) | | April 11, 2024

Study Identifies Factors That Affect Antibiotic Prescribing for Acne

Five themes affect long-term prescribing, including perceived lack of evidence to justify change, discomfort discussing contraception

By Elana Gotkine (HealthDay News) | | April 11, 2024

Low Adherence to Follow-Up Seen for Primary Invasive Melanoma

Greater adherence to annual dermatology visits leads to reduced melanoma-specific mortality

By Dermsquared Editorial Team | | April 11, 2024

Oral Minoxidil Not Superior to Topical for Male Androgenetic Alopecia

Oral minoxidil can be an option for patients who would rather take an oral therapy or cannot tolerate topical treatment

By Dermsquared Editorial Team | | April 11, 2024

24 of 1200

Headline from the Week of February 09 - 15, 2026

Second Annual National Cancer Database Report Presented for 2022

By Elana Gotkine (HealthDay News) | | February 11, 2026

Presurgical Pembrolizumab Beneficial for Desmoplastic Melanoma

By Elana Gotkine (HealthDay News) | | February 11, 2026